DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sandborn WJ, Feagan BG, Marano C. et al.
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
Gastroenterology 2014;
146: 85-95 ; quiz e14–15
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.